Tuberculosis: yesterday, today and tomorrow
Chris Lowbridge A C and Anna P Ralph B D
+ Author Affiliations
- Author Affiliations
A Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, PO Box 41096, Casuarina, NT 0811, Australia
B Department of Infectious Diseases, Royal Darwin Hospital, 105 Rocklands Drive, TIWI, NT 0801, Australia
C Email: christopher.lowbridge@menzies.edu.au
D Email: anna.ralph@menzies.edu.au
Microbiology Australia 41(4) 192-195 https://doi.org/10.1071/MA20052
Published: 20 October 2020
Abstract
Tuberculosis (TB) remains an important public health challenge globally and in Australia. For the more than 10 million people who become sick with TB each year, the disease can cause immense personal and economic hardship, including loss of income and education through ill health, prolonged and arduous treatment, and stigmatisation – perpetuating a cycle of disadvantage. Past efforts to control TB have taught us much about modern disease control and public health. As the world grapples with the coronavirus (COVID-19) pandemic, the response to TB provides valuable lessons which can inform our response to COVID-19.
References
[1] Gagneux, S. (2018) Ecology and evolution of Mycobacterium tuberculosis. Nat. Rev. Microbiol. 16, 202–213.| Ecology and evolution of Mycobacterium tuberculosis.Crossref | GoogleScholarGoogle Scholar | 29456241PubMed |
[2] Chisholm, R.H. et al. (2016) Controlled fire use in early humans might have triggered the evolutionary emergence of tuberculosis. Proc. Natl. Acad. Sci. USA 113, 9051–9056.
| Controlled fire use in early humans might have triggered the evolutionary emergence of tuberculosis.Crossref | GoogleScholarGoogle Scholar | 27457933PubMed |
[3] Paulson, T. (2013) Epidemiology: a mortal foe. Nature 502, S2–S3.
| Epidemiology: a mortal foe.Crossref | GoogleScholarGoogle Scholar | 24108078PubMed |
[4] Barberis, I. et al. (2017) The history of tuberculosis: from the first historical records to the isolation of Koch’s bacillus. J. Prev. Med. Hyg. 58, E9–E12.
| 28515626PubMed |
[5] Centers for Disease Control and Prevention (2016) History: World TB Day. https://www.cdc.gov/tb/worldtbday/history.htm (accessed 17 June 2020).
[6] de la Rua-Domenech, R. (2006) Human Mycobacterium bovis infection in the United Kingdom: incidence, risks, control measures and review of the zoonotic aspects of bovine tuberculosis. Tuberculosis (Edinb.) 86, 77–109.
| Human Mycobacterium bovis infection in the United Kingdom: incidence, risks, control measures and review of the zoonotic aspects of bovine tuberculosis.Crossref | GoogleScholarGoogle Scholar | 16257579PubMed |
[7] Luca, S. and Mihaescu, T. (2013) History of BCG vaccine. Maedica (Buchar.) 8, 53–58.
[8] Keshavjee, S. and Farmer, P.E. (2012) Tuberculosis, drug resistance, and the history of modern medicine. N. Engl. J. Med. 367, 931–936.
| Tuberculosis, drug resistance, and the history of modern medicine.Crossref | GoogleScholarGoogle Scholar | 22931261PubMed |
[9] Australian Institute of Health and Welfare (2006) Mortality over the twentieth century in Australia: trends and patterns in major causes of death. Mortality Surveillance Series, Australian Institute of Health and Welfare, Canberra.
[10] National Health and Medical Research Council of Australia (2020) History of tuberculosis control in Australia. https://www.nhmrc.gov.au/about-us/resources/impact-case-studies/resources/history-tuberculosis-control-australia (accessed 17 June 2020).
[11] Toms, C. et al. (2017) Tuberculosis notifications in Australia, 2014. Commun. Dis. Intell. Q. Rep. 41, E247–E263.
| 29720074PubMed |
[12] Adeiza, M. et al. (2014) HIV-associated tuberculosis: a sub-saharan African perspective. Sub-Saharan African Journal of Medicine 1, 1–14.
| HIV-associated tuberculosis: a sub-saharan African perspective.Crossref | GoogleScholarGoogle Scholar |
[13] World Health Organization (2020) Module 1: prevention (tuberculosis preventive treatment). In WHO Consolidated Guidelines on Tuberculosis. World Health Organization.
[14] Kaushik, N. et al. (2018) Post-migration follow-up programme for migrants at increased risk of developing tuberculosis: a cohort study. ERJ Open Res. 4, 00008-02018.
| Post-migration follow-up programme for migrants at increased risk of developing tuberculosis: a cohort study.Crossref | GoogleScholarGoogle Scholar | 30018973PubMed |
[15] World Health Organization (2018) The End TB Strategy: global strategy and targets for tuberculosis prevention, care and control after 2015. World Health Organization, Geneva.
[16] Sahu, S. et al. (2019) After the UNGA high-level meeting on tuberculosis - what next and how? Lancet Glob. Health 7, e558–e560.
| After the UNGA high-level meeting on tuberculosis - what next and how?Crossref | GoogleScholarGoogle Scholar | 30876836PubMed |
[17] World Health Organization (2019) Global tuberculosis report 2019. World Health Organization, Geneva.
[18] World Health Organization (2020) Global tuberculosis database. https://www.who.int/tb/country/data/download/en/ (accessed 17 June 2020).
[19] Houben, R.M.G.J. and Dodd, P.J. (2016) The global burden of latent tuberculosis infection: A re-estimation using mathematical modelling. PLoS Med. 13, e1002152.
| The global burden of latent tuberculosis infection: A re-estimation using mathematical modelling.Crossref | GoogleScholarGoogle Scholar |
[20] Getahun, H. et al. (2015) Latent Mycobacterium tuberculosis infection. N. Engl. J. Med. 372, 2127–2135.
| Latent Mycobacterium tuberculosis infection.Crossref | GoogleScholarGoogle Scholar | 26017823PubMed |
[21] Devlin, S. and Passmore, E. (2013) Ongoing transmission of tuberculosis in Aboriginal communities in NSW. NSW Public Health Bull. 24, 38–42.
| Ongoing transmission of tuberculosis in Aboriginal communities in NSW.Crossref | GoogleScholarGoogle Scholar |
[22] Bainomugisa, A. et al. (2019) Cross-border movement of highly drug-resistant Mycobacterium tuberculosis from Papua New Guinea to Australia through Torres Strait Protected Zone, 2010–2015. Emerg. Infect. Dis. 25, 406–415.
| Cross-border movement of highly drug-resistant Mycobacterium tuberculosis from Papua New Guinea to Australia through Torres Strait Protected Zone, 2010–2015.Crossref | GoogleScholarGoogle Scholar | 30789135PubMed |
[23] Schwartzman, K. et al. (2005) Domestic returns from investment in the control of tuberculosis in other countries. N. Engl. J. Med. 353, 1008–1020.
| Domestic returns from investment in the control of tuberculosis in other countries.Crossref | GoogleScholarGoogle Scholar | 16148286PubMed |
[24] Marks, G.B. et al. (2019) Community-wide screening for tuberculosis in a high-prevalence setting. N. Engl. J. Med. 381, 1347–1357.
| Community-wide screening for tuberculosis in a high-prevalence setting.Crossref | GoogleScholarGoogle Scholar | 31577876PubMed |
[25] Lestari, T. et al. (2019) Bridging the knowledge-practice gap in tuberculosis contact management in a high-burden setting: a mixed-methods protocol for a multicenter health system strengthening study. Implement. Sci. 14, 31.
| Bridging the knowledge-practice gap in tuberculosis contact management in a high-burden setting: a mixed-methods protocol for a multicenter health system strengthening study.Crossref | GoogleScholarGoogle Scholar | 30890160PubMed |
[26] Morris, L. et al. (2019) The emergency response to multidrug-resistant tuberculosis in Daru, Western Province, Papua New Guinea, 2014-2017. Public Health Action 9, S4–S11.
| The emergency response to multidrug-resistant tuberculosis in Daru, Western Province, Papua New Guinea, 2014-2017.Crossref | GoogleScholarGoogle Scholar | 31580333PubMed |
[27] World Health Organization (2020) Module 3: diagnosis (rapid diagnostics for tuberculosis detection). In WHO Consolidated Guidelines on Tuberculosis. World Health Organization.
[28] World Health Organization (2020) Module 4: treatment (drug-resistant tuberculosis treatment). In WHO Consolidated Guidelines on Tuberculosis, World Health Organization.
[29] Frick, M. (2019) Pipeline Report 2019: Tuberculosis Vaccines. Treatment Action Group, New York. https://www.treatmentactiongroup.org/resources/pipeline-report/2019-pipeline-report/ (accessed 11 September 2020).
[30] Tait, D.R. et al. (2019) Final analysis of a trial of M72/AS01E vaccine to prevent tuberculosis. N. Engl. J. Med. 381, 2429–2439.
| Final analysis of a trial of M72/AS01E vaccine to prevent tuberculosis.Crossref | GoogleScholarGoogle Scholar | 31661198PubMed |
[31] Sutarsa, I.N. et al. (2020) No work, no money: how self-isolation due to COVID-19 pandemic punishes the poor in Indonesia. https://theconversation.com/no-work-no-money-how-self-isolation-due-to-covid-19-pandemic-punishes-the-poor-in-indonesia-134141 (accessed 22 July 2020).
